Biotechnology This Biotech Reprogrammes Our Own Cells To Heal The Body – Enlivex Therapeutics (NASDAQ:ENLV) Read more
Biotechnology Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis – Enlivex Therapeutics (NASDAQ:ENLV) Read more
Biotechnology Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals – Enlivex Therapeutics (NASDAQ:ENLV) Read more